ADT Intensification might be the resort to delay biochemical progression in High risk biochemical relapse (BCR) #prostate cancer after Radical Prostatectomy. According to preliminary results of the phase III “PRESTO” study, the addition of #apalutamide or #abiraterone acetate + prednisolone to #ADT lead to prolongation of biochemical PFS (24 and 26 mo, respectively) compared to ADT alone (20 mo). This was WITHOUT affection of “time to testosterone recovery- TTTR” an important QoL parameter when using ADT.
.png)